Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.75 USD | 0.00% | -6.25% | +36.36% |
Apr. 19 | Nuo Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Mar. 19 | Exor-backed NUO invests in Italian teenage clothing chain Subdued | RE |
Financials (USD)
Sales 2022 | 112K | Sales 2023 | 609K | Capitalization | 24.33M |
---|---|---|---|---|---|
Net income 2022 | -3M | Net income 2023 | -3M | EV / Sales 2022 | 543 x |
Net cash position 2022 | 1.72M | Net cash position 2023 | 673K | EV / Sales 2023 | 38.9 x |
P/E ratio 2022 |
-18.9
x | P/E ratio 2023 |
-7.3
x | Employees | 9 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 40.7% |
1 week | -6.25% | ||
Current month | -6.25% | ||
1 month | -21.05% | ||
3 months | +22.95% | ||
6 months | +25.00% | ||
Current year | +36.36% |
Managers | Title | Age | Since |
---|---|---|---|
David Jorden
CEO | Chief Executive Officer | 61 | 08-09-18 |
Peter Clausen
COO | Chief Operating Officer | 58 | 08-08-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
C. Winzer
BRD | Director/Board Member | 67 | 09-01-29 |
David Jorden
CEO | Chief Executive Officer | 61 | 08-09-18 |
Paul Mintz
BRD | Director/Board Member | 75 | 17-04-06 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-15 | 0.75 | 0.00% | 1,000 |
24-05-14 | 0.75 | -6.25% | 1,000 |
24-05-08 | 0.8 | +0.13% | 6,384 |
Delayed Quote OTC Markets, May 15, 2024 at 09:51 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+36.36% | 33.18M | |
+7.52% | 113B | |
+11.38% | 106B | |
+0.90% | 22.27B | |
-12.64% | 22.22B | |
-4.45% | 19.43B | |
-37.85% | 17.87B | |
-8.58% | 17.24B | |
+7.77% | 14.29B | |
+37.41% | 12.52B |
- Stock Market
- Equities
- AURX Stock